We investigated the association of the European lactase persistence haplotype block with prostate cancer risk using genome-wide meta-analysis statistics of prostate cancer from 79,194 prostate cancer cases and 61,112 controls of the PRATICAL Consortium Oncoarray database (Schumacher et al., 2018). The gene discussed is LCT; the disease is prostate cancer.